Herpesviruses in patients with drug hypersensitivity syndrome: Culprits, cofactors or innocent bystanders?

Dermatology

Volumn 213, Issue 4, 2006, Pages 273-276

  Tas, S ^a   Simonart, T ^b  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTICONVULSIVE AGENT; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR ALPHA;

CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EDITORIAL; EOSINOPHILIA; FEVER; HEMATOLOGIC DISEASE; HEPATITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HYPOGAMMAGLOBULINEMIA; IMMUNOPATHOGENESIS; LEUKOCYTOSIS; LYMPHADENOPATHY; LYMPHOCYTE; PRIORITY JOURNAL; RASH; SIDE EFFECT; SYNDROME; VIRUS PATHOGENESIS; VIRUS REACTIVATION;

CAUSALITY; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; SENSITIVITY AND SPECIFICITY; SYNDROME; VIRUS ACTIVATION;

EID: 33751509881     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096188     Document Type: Editorial

References (29)

1. Sullivan JR, Shear NH: The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357-364.
2. Tas S, Simonart T: Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;206:353-356.
3. Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S: Predisposition to nevirapine hypersensitivity associated with HLA-DRB1 *0101 and abrogated by low CD4 T-cell counts. AIDS 2005;19:97-99.
4. Poszepczynska-Guigne E, Revuz J, Roujeau JC: Mécanismes immunologiques des réactions cutanées aux médicaments. Ann Dermatol Vénéréol 2005;132:177-183.
5. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux JL, Grange MJ, Grossin M, Navratil E, Crickx B, Belaich S: Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997;137:605-608.
6. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B: Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137:301-304.
7. Fujino Y, Nakajima M, Inoue H, Kusuhara T, Yamada T: Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann Neurol 2002;51:771-774.
8. Hashimoto K, Yasukawa M, Tohyama M: Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003;3:255-260.
9. Kano Y, Inaoka M, Shiohara T: Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004;140:183-188.
10. Aihara M, Mitani M, Kakemizu N, Yamakawa Y, Inomata N, Ito N, Komatsu H, Aihara Y, Ikezawa Z: Human herpesvirus infection in drug-induced hypersensitivity syndrome, toxic epidermal necrolysis and Stevens-Johnson syndrome. Allergol Int 2004;53:23-29.
11. Yagami A, Yoshikawa T, Asano Y, Koie S, Shiohara T, Matsunaga K: Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7. Dermatology 2006;213:341-344.
12. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B: Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003;148:1032-1034.
13. Hara H, Kobayashi M, Yokoyama A, Tochigi M, Matsunaga A, Shimizu H, Goshima J, Suzuki H: Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. Dermatology 2005;211:159-161.
14. Mitani N, Aihara M, Yamakawa Y, Yamada M, Itoh N, Mizuki N, Ikezawa Z: Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol 2005;75:430-434.
15. Janela B, Descamps V, Picard D, Rogez S, D'Incam M, Bernard P, Chevrant-Breton J, Milpied-Homsi B, Bonnetblanc JM, Barbaud A, Dupin N, Doutre MS, Jacquot S, Roujeau JC, Tron F, Joly P, Musette P: Rôle des réactivations virales sur la réponse lymphocytaire T, au cours du syndrome d'hypersensibilité médicamenteuse. Ann Dermatol Vénéréol 2005;132:9S37.
16. Samuelson J: Infectious diseases; in Cortran R, Kumar V, Collins T (eds): Robbins Pathologic Basis of Disease, ed 6. Philadelphia, Saunders Co, 1999, p 330.
17. Hill B: The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
18. Pirmohamed M, Naisbitt DJ, Gordon F, Park BK: The danger hypothesis - Potential role in idiosyncratic drug reactions. Toxicology 2002;181:55-63.
19. Akashi K, Eizuru Y, Sumiyoshi Y, Minematsu T, Hara S, Harada M, Kikuchi M, Niho Y, Minamishima: Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329:168-171.
20. Wong GA, Shear NH: Is a drug alone sufficient to cause the drug hypersensitivity syndrome? Arch Dermatol 2004;140:226-230.
21. Rothman KJ, Greenland S: Causation and causal inference; in Rothman KJ, Greenland S (eds): Modern Epidemiology. Philadelphia, Lippincott-Raven, 1998, pp 7-28.
22. Shiohara T, Kano Y: Are viral infections responsible for the development of drug-induced hypersensitivity syndrome as well as graft-versus-host diseases? Dermatology 2005;210:259-260.
23. Lipsker D, Saurat JH: A new concept: paraviral eruptions. Dermatology 2005;211:309-311.
24. Nakashima H, Yamane K, Ihn H, Nakamura K, Watanabe R, Kuwano Y, Takekoshi T, Watanabe T, Hattori N, Fujimoto M, Tamaki K: Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and increase in serum IgE level. Dermatology 2005;210:349-352.
25. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV: Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J Infect Dis 2002;185:110-113.
26. Desachy A, Ranger-Rogez S, François B, Venot C, Traccard I, Gastinne H, Denis F, Vignon P: Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis 2001;32:197-203.
27. Yeung CK, Ma SY, Hon C, Peiris M, Chan HH: Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital. Acta Derm Venereol 2003;83:179-182.
28. Aihara Y, Ito S, Kobayashi Y, Aihara M: Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. Allergy 2004;59:118.
29. Kano Y, Inaoka M, Sakuma K, Shiohara T: Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 2005;15;209:165-167.